Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeanette Payne

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 2, 2022
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiencyJeanette Payne, Glaivy Batsuli, Andrew D Leavitt, et al.
British Journal of Haematology|June 25, 2009
The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99Christopher Mitchell, Jeanette Payne, Rachel Wade, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 4, 2018
Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiencyMichael Mitchell, Michael Gattens, Kaan Kavakli, et al.
Archives of Disease in Childhood|January 21, 2016
Venous thromboembolism occurring during adolescenceTina Biss, Raza Alikhan, Jeanette Payne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 17, 2021
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus updateDaniel P Hart, Jayanthi Alamelu, Neha Bhatnagar, et al.
British Journal of Clinical Pharmacology|August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia BSjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
Blood|January 5, 2013
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine productionSamuel C C Chiang, Jakob Theorell, Miriam Entesarian, et al.
Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 2, 2022
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiencyJeanette Payne, Glaivy Batsuli, Andrew D Leavitt, et al.
British Journal of Haematology|June 25, 2009
The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99Christopher Mitchell, Jeanette Payne, Rachel Wade, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 4, 2018
Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiencyMichael Mitchell, Michael Gattens, Kaan Kavakli, et al.
Archives of Disease in Childhood|January 21, 2016
Venous thromboembolism occurring during adolescenceTina Biss, Raza Alikhan, Jeanette Payne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 17, 2021
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus updateDaniel P Hart, Jayanthi Alamelu, Neha Bhatnagar, et al.
British Journal of Clinical Pharmacology|August 11, 2023
A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia BSjoerd F Koopman, Tine M H J Goedhart, Laura H Bukkems, et al.
Blood|January 5, 2013
Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine productionSamuel C C Chiang, Jakob Theorell, Miriam Entesarian, et al.
Thrombosis and Haemostasis|May 6, 2020
A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A PatientsLaura H Bukkems, Jessica M Heijdra, Mary Mathias, et al.
Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
Pageof 1